Torthaí cuardaigh - Line Ganlonon

Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial de réir Richard Odame Phillips, J. Robert, Kabiru Mohamed Abass, William A. Thompson, Fred Stephen Sarfo, Wilson Tuah, Godfred Sarpong, Thierry Gateau, Annick Chauty, Raymond Omollo, Michael Ochieng Otieno, Thaddaeus Egondi, Edwin Ampadu, Didier Agossadou, Estelle Marion, Line Ganlonon, Mark Wansbrough‐Jones, J Grosset, John M. MacDonald, Terry Treadwell, Paul Saunderson, Albert Paintsil, Linda Lehman, Michael Frimpong, Nanaa Francisca Sarpong, Raoul Saizonou, Alexandre Tiendrébéogo, Sally-Ann Ohene, Ymkje Stienstra, Kingsley Asiedu, Tjip S. van der Werf, Samuel Osei Mireku, Justice Abotsi, Joseph Ken Adu Poku, Richard Asamoah-Frimpong, Bright Osei-Wusu, Edward Sarpong, Beatrice Konadu, Ernest Opoku, Mark Forson, Mathias Ndogyele, Elizabeth Ofori, Felicity Aboagye, Thomas Berko, George Amofa, Anastasia Nsiah, Joyce Mensah-Bonsu, Joseph Ofori Nyarko, Yaw Ampem Amoako, Elliot Koranteng Tannor, Justice K. Boakye-Appiah, Aloysius Dzigbordi Loglo, Mabel Sarpong-Duah, Bernadette Agbavor, Marie Françoise Ardent, Arnaud Yamadjako, Naomi Adanmado Gersande, Ambroise Adeye, Martial Kindjinou, Akpolan, Gbètogo Maxime Kiki, Espoir Sodjinou, Clémence Guegnard, Sandor-Adrian Klis, Kristien Velding, Till F. Omansen, David Ofori‐Adjei, Sarah Eyangoh, A.J. Knell, William R. Faber